Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice Robertson

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Acta Neuropathologica Communications|October 26, 2019
Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levelsShangxi Xiao, Paul M McKeever, Agnes Lau, et al.
Advances in Neurobiology|June 20, 2018
Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLDMarc Shenouda, Ashley B Zhang, Anna Weichert, et al.
Biochimie|February 22, 2003
Pathways to motor neuron degeneration in transgenic mouse modelsJanice Robertson, Jasna Kriz, Minh Dang Nguyen, et al.
Frontiers in Neuroscience|July 8, 2022
A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALSMarc Shenouda, Shangxi Xiao, Laura MacNair, et al.
Journal of Neurochemistry|June 22, 2006
Defective axonal transport of neurofilament proteins in neurons overexpressing peripherinStéphanie Millecamps, Janice Robertson, Roxanne Lariviere, et al.
Cell Reports|February 23, 2023
Loss of C9orf72 perturbs the Ran-GTPase gradient and nucleocytoplasmic transport, generating compositionally diverse Importin β-1 granulesPhilip McGoldrick, Agnes Lau, Zhipeng You, et al.
Neurology|March 21, 2018
Clinical Reasoning: A 42-year-old man with unilateral leg weaknessRaphael Schneider, Anna Weichert, Ekaterina Rogaeva, et al.
Journal of Neuropathology and Experimental Neurology|December 20, 2007
Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosisTeresa Sanelli, Shangxi Xiao, Patrick Horne, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 18, 2026
Small molecule JRMS modulating importin-β1 chaperone activity as a therapeutic strategy reducing TDP-43 pathologyMarc Shenouda, Sandra Shenouda, Bryan Kartono, et al.
Acta Neuropathologica Communications|June 28, 2025
C9orf72 deficiency impairs the autophagic response to aggregated TDP-25 and exacerbates TDP-25-mediated neurodegeneration in vivoLilian Tsai-Wei Lin, Marc Shenouda, Philip McGoldrick, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Acta Neuropathologica Communications|October 26, 2019
Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levelsShangxi Xiao, Paul M McKeever, Agnes Lau, et al.
Advances in Neurobiology|June 20, 2018
Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLDMarc Shenouda, Ashley B Zhang, Anna Weichert, et al.
Biochimie|February 22, 2003
Pathways to motor neuron degeneration in transgenic mouse modelsJanice Robertson, Jasna Kriz, Minh Dang Nguyen, et al.
Frontiers in Neuroscience|July 8, 2022
A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALSMarc Shenouda, Shangxi Xiao, Laura MacNair, et al.
Journal of Neurochemistry|June 22, 2006
Defective axonal transport of neurofilament proteins in neurons overexpressing peripherinStéphanie Millecamps, Janice Robertson, Roxanne Lariviere, et al.
Cell Reports|February 23, 2023
Loss of C9orf72 perturbs the Ran-GTPase gradient and nucleocytoplasmic transport, generating compositionally diverse Importin β-1 granulesPhilip McGoldrick, Agnes Lau, Zhipeng You, et al.
Neurology|March 21, 2018
Clinical Reasoning: A 42-year-old man with unilateral leg weaknessRaphael Schneider, Anna Weichert, Ekaterina Rogaeva, et al.
Journal of Neuropathology and Experimental Neurology|December 20, 2007
Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosisTeresa Sanelli, Shangxi Xiao, Patrick Horne, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 18, 2026
Small molecule JRMS modulating importin-β1 chaperone activity as a therapeutic strategy reducing TDP-43 pathologyMarc Shenouda, Sandra Shenouda, Bryan Kartono, et al.
Acta Neuropathologica Communications|June 28, 2025
C9orf72 deficiency impairs the autophagic response to aggregated TDP-25 and exacerbates TDP-25-mediated neurodegeneration in vivoLilian Tsai-Wei Lin, Marc Shenouda, Philip McGoldrick, et al.
Pageof 9